[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 489
Citations 0
Lab Reports
August 4, 2015

New Study of Candidate Vaccine to Prevent Chlamydia

JAMA. 2015;314(5):442. doi:10.1001/jama.2015.8389

No vaccine currently exists to protect against infection with the sexually transmitted bacterium Chlamydia trachomatis, which can cause female infertility and ectopic pregnancies and is the leading cause of preventable blindness in developing countries. Now, however, investigators at Harvard Medical School, in Boston, present a promising candidate vaccine consisting of UV light–inactivated C trachomatis tightly conjugated to charged nanoparticles carrying an adjuvant to boost the immune response (Stary G et al. Science. 2015;348[6241]:aaa8205).

First Page Preview View Large
First page PDF preview
First page PDF preview
×